IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy

Clinical trial NCT03152058 · RECRUITING

Trial details

NCT number: NCT03152058
Sponsor: David Ware Branch
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

High Risk Pregnancy Pregnancy Complications Antiphospholipid Syndrome in Pregnancy Lupus Anticoagulant Disorder

Start date: 2017-05-17
Primary completion: 2027-12-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.